Wingstop Inc. (WING)
NASDAQ · Consumer Cyclical
Wingstop Inc. Operating Income 2013–2025
Wingstop Inc. annual/quarterly operating income history and growth rate from 2013 to 2026. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- Wingstop Inc. operating income for the quarter ending March 28, 2026 was 50.4 M, a 31.75% increase year-over-year.
- Wingstop Inc. operating income for the twelve months ending March 28, 2026 was 182.9 M, a 18.41% increase year-over-year.
- Wingstop Inc. annual operating income for 2025 was 179.3 M, a 8.26% increase from 2024.
- Wingstop Inc. annual operating income for 2024 was 165.6 M, a 47.09% increase from 2023.
- Wingstop Inc. annual operating income for 2023 was 112.6 M, a 22.47% increase from 2022.
- Wingstop Inc. annual operating income for 2022 was 91.9 M.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
West Pharmaceutical Services, Inc. Operating Income — FAQ
West Pharmaceutical Services, Inc. (WING) operating income over the last 13 years — annual and quarterly figures with year-over-year growth and charts.
What is West Pharmaceutical Services, Inc.'s operating income?
West Pharmaceutical Services, Inc. (WING) reported operating income of $179M for fiscal 2025.
Where can I see WING's operating income history?
The chart and table above show West Pharmaceutical Services, Inc.'s operating income by year and by quarter, including the growth rate.